Myeloid-derived suppressor cells in transplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 6, 2010, Pages 765-768

  Dilek, Nahzli ^a,b,c   Van Rompaey, Nicolas ^d   Le Moine, Alain ^d   Vanhove, Bernard ^a,b,c  

^a HÔTEL DIEU   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

immunosuppression; myeloid cells; regulatory T cells; transplant tolerance

Indexed keywords

CD 28 SPECIFIC MODULATING ANTIBODY; CYTOKINE ANTIBODY; ENDOTOXIN; HEME OXYGENASE 1; INTERLEUKIN 2; OXYGENASE INHIBITOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; INNATE IMMUNITY; KIDNEY GRAFT REJECTION; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; REVIEW; SUPPRESSOR CELL; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; MICE; MODELS, ANIMAL; MYELOID CELLS; ORGAN TRANSPLANTATION; RATS; TRANSPLANTATION TOLERANCE;

EID: 78649651737     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283401742     Document Type: Review

References (32)

1. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
2. Haspot F, Séveno C, Dugast A, et al. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant 2005; 5:2339-2348.
3. +cells. J Immunol 2006; 176:3915-3922.
4. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4:762-774.
5. Chauveau C, Rémy S, Royer PJ, et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 2005; 106:1694-1702.
6. Tzachanis D, Berezovskaya A, Nadler LM, Boussiotis VA. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternativelyactivated macrophages,which suppressT-cell responses. Blood 2002; 99:1465-1473.
7. Seino KI, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001; 98:2577-2581.
8. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplanttolerance. Nat Rev Immunol 2007; 7:610-621.
9. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res 2006; 312:2169-2179.
10. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mito-genic stimuli. Blood 2002; 99:3838-3843.
11. Brem-Exner BG, Sattler C, Hutchinson JA, et al. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 2008; 180:335-349.
12. Serafini P, De Santo C, Marigo I, et al. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 2004; 53:64-72.
13. Mazzoni A, Bronte V, Visintin A, et al. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 2002; 168:689-695.
14. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998; 160:5729-5734.
15. Brito C, Naviliat M, Tiscornia AC, et al. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairmentoftyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol 1999; 162:3356-3366.
16. + myeloid cells. Cancer Res 2006; 66: 6807-6815.
17. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-174.
18. Corzo CA, Cotter MJ, Cheng P, et al. Mechanism regulating reactive oxygen species intumor-induced myeloid-derived suppressor cells. J Immunol 2009; 182:5693-5701.
19. Almand B, Clark J I, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001; 166:678-689.
20. Prins RM, Scott GP, Merchant RE, Graf MR. Irradiated tumor cell vaccine for treatment of anesta blishedglioma. II: Expansionof my eloid suppressor cells that promote tumor progression. Cancer Immunol Immunother2002;51:190-199.
21. Zhou Z, French DL, Ma G, et al. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 2010; 28:620-632.
22. Dugast A, Haudebourg T, Coulon F, et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008; 180:7898-7906.
23. + T regulatory cells prolongs skin allograft survival in mice. Cell Transplant (in press).
24. De Wilde V, Van Rompaey N, Hill M, et al. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009; 9:2034-2047.
25. + population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204:1463-1474.
26. Alegre M, Leemans J, Le Moine A, et al. The multiple facets of toll-like receptors in transplantation biology. Transplantation 2008; 86:1-9.
27. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010; 50:323-354.
28. Soares MP, Bach FH. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med 2009; 15:50-58.
29. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192:1015-1026.
30. Natarajan S, Thomson AW. Tolerogenic dendritic cells and myeloid-derived suppressor cells: potential for regulation and therapy of liver auto-and alloimmunity. Immunobiology 2010. http://www.ncbi.nlm.nih.gov.gate2.inist. fr/pubmed/20605054. [Accessed 27 July 2010]
31. Sander LE, Sackett SD, Dierssen U, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207:1453-1464.
32. Marigo I, Bosio E, Solito S, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 2010; 32:790-802.